Anika Therapeutics, Inc. (ANIK)
Makes injectable treatments to reduce joint pain and repair cartilage damage.
$15.15+0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+75.3%
The outlook
ANIK is trading above both its 50- and 200-day moving averages, positioning it in the upper portion of its 52-week range. Analyst coverage leans bullish, with the average price target sitting roughly 16% above the current price. The stock shows strength in its recent trend relative to longer-term levels.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range84% of the way from its 52-week low to high
Price targetAvg target +16% vs current price
Analyst price target
~12-month · 2 analysts$17.50average target+15.5% vs now
Now $15.15
Low $17.00High $18.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$201.6M
52-wk high
$16.49
52-wk low
$7.87
50-day avg
$14.99
200-day avg
$12.36
Trailing P/E
—